Evidence map›Paper›PMID 42303972›Full record

ArticleNature communications2026

Structural basis and immunogenic efficacy of porcine circovirus type 3 virus-like particle.

Jinfu Su, Xiaodan Tong, Yanan Jiang, Yu Li, He Yan, Yan Liu, Yanwei Wang, Xiaorui Su, Zhe Sun, Mengyue Wang and 6 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jinfu Su *State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen, China.ORCID http://orcid.org/0009-0004-9308-3630
Xiaodan Tong *National Research Center for Veterinary Medicine, Luoyang, China.
Yanan Jiang *State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen, China.
Yu LiState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen, China.ORCID http://orcid.org/0009-0008-5392-8917
He YanNational Research Center for Veterinary Medicine, Luoyang, China.
Yan LiuNational Research Center for Veterinary Medicine, Luoyang, China.
Yanwei WangNational Research Center for Veterinary Medicine, Luoyang, China.
Xiaorui SuNational Research Center for Veterinary Medicine, Luoyang, China.
Zhe SunNational Research Center for Veterinary Medicine, Luoyang, China.
Mengyue WangNational Research Center for Veterinary Medicine, Luoyang, China.
Ningshao XiaState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen, China.ORCID http://orcid.org/0000-0003-0179-5266
Mihnea BostinaDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
Shaowei LiState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen, China. shaowei@xmu.edu.cn.ORCID http://orcid.org/0000-0002-3374-1038
Wenqiang PangNational Research Center for Veterinary Medicine, Luoyang, China. pangwenqiang@pulike.com.cn.
Qingbing ZhengState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen, China. qbzheng@xmu.edu.cn.ORCID http://orcid.org/0000-0002-7516-9965
Kegong TianNational Research Center for Veterinary Medicine, Luoyang, China. vetvac@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Porcine circovirus type 3 (PCV3) is an emerging swine pathogen associated with reproductive failure and systemic inflammation, but vaccines for related PCV2 provide limited cross-protection. Here, we determine high-resolution cryo-EM structures of PCV3 capsid protein assembled into virus-like particles (VLPs) and of PCV3 VLPs bound to the PCV3-specific antibody 2B5. The structures reveal differences from PCV2 in surface loops and define a conserved 2B5 epitope mainly involving the BC, EF and HI loops, providing a structural basis for PCV3-specific recognition. PCV3 VLPs induce sustained antibody responses in mice and pigs. In a pig challenge model, VLP immunization prevents viremia and viral replication in lungs and lymph nodes, as measured by quantitative PCR and in situ hybridization, with protection maintained for at least five months after boosting. These findings support PCV3 VLPs as a vaccine candidate against PCV3 infection.

Indexed as

Circoviridae InfectionsCircovirusSwine DiseasesVaccines, Virus-Like ParticleViral VaccinesAnimalsAntibodies, ViralCapsid ProteinsCryoelectron MicroscopyEpitopesFemaleMiceSwineAntibodies, ViralCapsid ProteinsEpitopesVaccines, Virus-Like ParticleViral Vaccines

Identifiers

PMID42303972
PMCPMC13434755

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.